Frazier Life Sciences and Alamar Biosciences launch Attovia Therapeutics to Unlock Potential of Novel Biparatopic Nanobody Platform Posted on June 20, 2023July 25, 2023 by fraziermwd
Chinook Therapeutics Enters into Agreement to be Acquired by Novartis AG Posted on June 12, 2023July 25, 2023 by fraziermwd
Carmot Therapeutics Raises $150 Million in Series E Equity Financing to Advance its Pipeline of Treatments for Obesity and Diabetes Posted on May 25, 2023August 29, 2023 by KBD Admin
Krystal Biotech Announces $160 Million Private Placement Equity Financing Posted on May 22, 2023July 25, 2023 by fraziermwd
Lassen Therapeutics Appoints Maria Fardis, PhD, MBA, as Chief Executive Officer Posted on May 4, 2023July 10, 2023 by fraziermwd
Cidara Therapeutics and Melinta Therapeutics Announce FDA Approval of REZZAYO™ (Rezafungin For Injection) For the Treatment of Candidemia and Invasive Candidiasis Posted on March 22, 2023July 10, 2023 by fraziermwd
Merck Completes Tender Offer to Acquire Imago BioSciences, Inc. Posted on January 11, 2023July 25, 2023 by fraziermwd
Enlaza Therapeutics Launches with $61 Million Financing to Advance the First Covalent Biologic Therapeutic Platform Posted on December 15, 2022July 10, 2023 by fraziermwd
Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer Posted on December 14, 2022July 10, 2023 by fraziermwd
NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular Disease Posted on November 23, 2022July 10, 2023 by fraziermwd
